Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remifentanil on Pruritus and Paresthesia Caused by Fospropofol Disodium Anesthesia
NCT07092384Completed
- Sponsor
- Tongji Hospital
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of remifentanil in pruritus and paresthesia (5 arms), sponsored by Tongji Hospital. Primary endpoint: Incidence of pruritus and paresthesia after administration of fospropofol disodium at 24 hours. Started Jul 2025; status: completed.
02
Drugs
remifentanil
03
Conditions
pruritusparesthesia
Beyond the preview
Go deeper on NCT07092384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07092384.